Epstein Secrets

g Wedge With Pharmaceutical Companies," the Washington Post <https://vvww.washingtonpost.com/health/2021/05/05/biden-waives-vaccine- patents/> (5/5, Al, Diamond, Pager, Stein, 10.52M) reports the Administration "threw its support behind a controversial proposal to waive intellectual property protections for

-protection-for- covid-19-vaccines-11620243518> (5/5, Al, Hayashi, Hopkins, Subscription Publication, 8.41M) reports the Pharmaceutical Research and Manufacturers of America said the decision will weaken supply chains and increase counterfeiting. PhRMA said in a statement, "This decision does nothing to address the real

protections." Under the headline "Biden Commits To Waiving Vaccine Patents, Driving Wedge With Pharmaceutical Companies," the Washington Post (5/5, Al, Diamond, Pager, Stein, 10.52M) reports the Administration "threw its support behind a controversial proposal to waive intellectual property protections for

erna's trade secrets." The Wall Street Journal (5/5, Al, Hayashi, Hopkins, Subscription Publication, 8.41M) reports the Pharmaceutical Research and Manufacturers of America said the decision will weaken supply chains and increase counterfeiting. PhRMA said in a statement, "This decision does nothing to address the real

protections." Under the headline "Biden Commits To Waiving Vaccine Patents, Driving Wedge With Pharmaceutical Companies," the Washington Post (5/5, Al, Diamond, Pager, Stein, 10.52M) reports the Administration "threw its support behind a controversial proposal to waive EFTA00149813 intellectual property

erna's trade secrets." The Wall Street Journal (5/5, Al, Hayashi, Hopkins, Subscription Publication, 8.41M) reports the Pharmaceutical Research and Manufacturers of America said the decision will weaken supply chains and increase counterfeiting. PhRMA said in a statement, "This decision does nothing to address the real